When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and Human Services secretary are bringing down the hammer. What happens when there is no middle ground? #vaccinations #HHS #biospace https://hubs.li/Q03kC5PN0
BioSpace Pro Recruitment Services
Staffing and Recruiting
Urbandale, Iowa 1,507 followers
BioSpace Pro will tap into our valuable community to proactively identify candidates for your critical roles.
About us
Having trouble filling your roles fast enough? Hiring biopharma professionals can be extremely challenging because they're so unlikely to apply. Luckily for you, there’s BioSpace Pro. Our recruitment services start with a consultation on your needs and covers the entire hiring process including pre-screening calls, interview scheduling and negotiations. No fees until they're hired.
- Website
-
https://marketing.biospace.com/biospace-pro/
External link for BioSpace Pro Recruitment Services
- Industry
- Staffing and Recruiting
- Company size
- 11-50 employees
- Headquarters
- Urbandale, Iowa
- Founded
- 1985
- Specialties
- Research, Development, Manufacturing, Production, Sales, Quality, Marketing, Sales & Service, Information Technology, Regulatory, Administration, and Engineering
Updates
-
AIRNA’s lead candidate AIR-001 works by correcting the most common pathologic mutation driving the rare disease alpha-1 antitrypsin deficiency. #funding #pharma #biospace https://hubs.li/Q03fgGkf0
-
Novo Nordisk will license UTB251, a triple hormone receptor agonist that in mid-2023 achieved promising weight reduction in a mid-stage study. #weightloss #biotech #biospace https://hubs.li/Q03d4wTM0
-
It’s early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions to make this approach a viable option and help ease the organ shortage crisis. #geneediting #organshortage #biospace https://hubs.li/Q03d4fNv0
-
Pfizer, facing increasing pressure from Novartis, is touting a Phase III win for Ibrance as the first clinical evidence supporting the CDK4/6 inhibitor class’ use in patients with a specific type of breast cancer. #cancer #pharma #biospace https://hubs.li/Q02_qtm50
-
The FDA on Monday signed off on Shorla Oncology’s Imkeldi, an oral solution indicated for the treatment of certain types of chronic myeloid leukemia and acute lymphoblastic leukemia, as well as other cancers such as myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis and dermatofibrosarcoma protuberans. #FDA #biospace https://hubs.li/Q02Zl5fQ0